AMRC Statement on EU Referendum Outcome

As the UK votes to leave the European Union, the Association of Medical Research Charities (AMRC), of which The Cure Parkinson's Trust is a member, issues a statement of its intentions.

Latest

An Overview of Drug Development for Parkinson's

Recently published research, conducted by Parkinson's research advocates and CPT, presents an encouraging overview of current agents in the pipeline for the treatment of Parkinson's. This report represents one of the first classifications and in-depth analysis of the Parkinson's clinical trials arena.
Rallying to the Challenge 2020

Join The Cure Parkinson’s Trust and Van Andel Institute on 24 and 25 September for this year’s ‘virtual’ Grand Challenges in Parkinson’s Disease and its parallel meeting Rallying to the Challenge.
The Ricky Road Run goes Virtual for 2020!

From Friday 17 July – Monday 3 August, 43 running enthusiasts took part in the ‘virtual’ Ricky Road Run in support of The Cure Parkinson’s Trust’s (CPT) pioneering Parkinson’s research.
Cure3 2020

Cure3 2020, the third edition of the acclaimed selling exhibition, will take place this September in support of CPT.

An Overview of Drug Development for Parkinson's

Recently published research, conducted by Parkinson's research advocates and CPT, presents an encouraging overview of current agents in the pipeline for the treatment of Parkinson's. This report represents one of the first classifications and in-depth analysis of the Parkinson's clinical trials arena.
Cure3 2020

Cure3 2020, the third edition of the acclaimed selling exhibition, will take place this September in support of CPT.
Helping the Research Community Restart their Studies

As researchers in the field of Parkinson’s take steps to invite patients back to take part in face-to-face studies, we'd like to hear your views about returning to participate in research in the UK.
CPT's Dr Richard Wyse Co-edits Prestigious Cochrane Report

CPT's Dr Richard Wyse is the co-editor of a recent Cochrane Report on GLP‐1 receptor agonists and their potential use in treating Parkinson's Disease
Further Evidence of Neuroprotection of Simvastatin in Parkinson's

Researchers in Israel have recently published an interesting new study which provides a novel insight and further independent support for simvastatin which CPT is clinically testing in people with Parkinson's.
'Cabbages and Kings Magazine' in support of CPT

Long term supporters from the Leicestershire, Northamptonshire and Rutland Committee led by Meriel Buxton have produced and printed a wonderful magazine 'Cabbages and Kings' to help raise funds for CPT’s research.
Blood Plasma Infusions for Parkinson's

Research has shown that infusions of blood plasma from young animal models can improve the health of older animal models, and a recent study of plasma infusions in people with Parkinson's warrants further investigations.
The “Raid Local” Cycle Challenge

On Sunday 28 June, over 1000 supporters of The Cure Parkinson’s Trust (CPT) took to the saddle to take part in the charity’s “Raid Local” cycle challenge, and have - so far - raised an astonishing £250,000 (including gift aid) for CPT’s vital research into a cure for Parkinson’s.
Parkinson's: the Absense of Appendixes & Tonsils

Recent research of large data in Sweden has shown removal of tonsils and appendixes reduces the risk of Parkinson's.
Astrocytes to Dopamine Neurons in One Step

A Chinese research group have shown that 'helper cells' in the brain called astrocytes can be converted to nerve cells, which then can go on to produce dopamine - the brain chemical lost in Parkinson's. This is exciting news, but further research is needed.

Breakthrough in stem cell treatment for Parkinson's

In a major breakthrough for the treatment of Parkinson's, researchers working with laboratory rats show it is possible to make dopamine cells from embryonic stem cells and transplant them into the brain.
Tom Isaacs

We are devastated to announce that Tom Isaacs, President and Co-founder of The Cure Parkinson’s Trust (CPT) died on Wednesday morning (31st May). Tom’s passing was unexpected and swift.
New Evidence Suggests Parkinson's Might Not Start in The Brain

A new study adds to a raft of new evidence which suggests Parkinson's starts in the gut...
Science news

Read the latest Parkinson's science and research news here.
Trials - Repurposed Drugs

Our International Linked Clinical Trials initiative (iLCT) identifies potential new treatments to slow, stop or reverse Parkinson’s disease by 'repurposing' or repositioning drugs that are approved to treat other conditions.
Apply for Funding
The NAC Trial - the facts
Our story
Diabetes Drug Potential Disease-Modifying Therapy

The study, published in The Lancet and funded by The Michael J. Fox Foundation for Parkinson’s Research (MJFF), supported by CPT found that people with Parkinson’s treated with Exenatide for one year performed better in motor tests than those on placebo.
Alpha-synuclein and Parkinson's

The Science of Parkinson's - Dr Simon Stott, Deputy Director of Research

Science news

Read the latest Parkinson's science and research news here. Read more

The Cure Collective

The Cure Collective is an opportunity to join like-minded individuals who are committed to help drive forward the quest to find a cure for Parkinson’s... Read more